Perinatal blood biomarkers for the identification of brain injury in very low birth weight growth-restricted infants

J Perinatol. 2021 Sep;41(9):2252-2260. doi: 10.1038/s41372-021-01112-8. Epub 2021 Jun 3.

Abstract

Objective: To determine if blood biomarkers measured at delivery and shortly after birth can identify growth-restricted infants at risk for developing severe brain injury.

Study design: In a cohort of very low birth weight neonates, fetal growth restricted (FGR) (birth weight <10%) were compared to non-FGR neonates, and within the FGR group those with brain injury were compared to those without. Biomarkers were measured in cord blood at delivery, and daily for the 1st 5 days of life.

Result: FGR was associated with significantly higher levels of interleukin (IL)-6, IL-8, IL-10, and lower levels of vascular endothelial growth factor (VEGF). FGR and brain injury were associated with significantly higher levels of IL-6, IL-8, IL-10, and glial fibrillary acidic protein (GFAP).

Conclusion: Interleukins may be involved in a common pathway contributing to both the development of growth restriction and brain injury, and GFAP may help identify brain injury within this growth-restricted group.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers / blood*
  • Birth Weight
  • Brain Injuries* / diagnosis
  • Female
  • Fetal Growth Retardation*
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Very Low Birth Weight*
  • Interleukins / blood
  • Pregnancy
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Biomarkers
  • Interleukins
  • Vascular Endothelial Growth Factor A